Coronavirus Disease 2019 Serial Testing Among Hospitalized Patients in a Midwest Tertiary Medical Center, July-September 2020.

Takaaki KobayashiAlexandra TrannelStephanie A HolleyMohammed A AlsuhaibaniOluchi J AbosiKyle E JennHolly MeachamLorinda L SheelerWilliam EtienneAngelique DainsFernando CasadoMary E KuklaEmily K WardBradley FordMichael B EdmondMelanie WellingtonDaniel J DiekemaJorge L Salinas

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)

We implemented serial coronavirus disease 2019 testing for inpatients with a negative test on admission. The conversion rate (negative to positive) on repeat testing was 1%. We identified patients during their incubation period and hospital-onset cases, rapidly isolated them, and potentially reduced exposures. Serial testing and infectiousness determination were resource intensive.

Keyphrases

coronavirus disease
end stage renal disease
emergency department
healthcare
newly diagnosed
chronic kidney disease
prognostic factors
high resolution
adverse drug
tandem mass spectrometry
acute care